Cargando…

The synergistic effect of depression and moderate chronic kidney disease on the all-cause and cardiovascular disease mortality among adults: a retrospective cohort study

BACKGROUND: The relationship between the coexistence of depression and moderate chronic kidney disease (CKD) and mortality is unclear. We aimed to investigate whether there is a synergistic effect of depression and moderate CKD on the all-cause and cardiovascular disease (CVD) mortality among adults...

Descripción completa

Detalles Bibliográficos
Autores principales: Meng, Fanchao, Qi, Yanjie, Chen, Xu, Yan, Xiuping, Huang, Huanhuan, He, Fan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9554995/
https://www.ncbi.nlm.nih.gov/pubmed/36221061
http://dx.doi.org/10.1186/s12882-022-02957-7
_version_ 1784806819132080128
author Meng, Fanchao
Qi, Yanjie
Chen, Xu
Yan, Xiuping
Huang, Huanhuan
He, Fan
author_facet Meng, Fanchao
Qi, Yanjie
Chen, Xu
Yan, Xiuping
Huang, Huanhuan
He, Fan
author_sort Meng, Fanchao
collection PubMed
description BACKGROUND: The relationship between the coexistence of depression and moderate chronic kidney disease (CKD) and mortality is unclear. We aimed to investigate whether there is a synergistic effect of depression and moderate CKD on the all-cause and cardiovascular disease (CVD) mortality among adults. METHODS: We studied 24,412 participants from the National Health and Nutrition Examination Survey 2005–2014 with a mortality follow-up assessment in 2015. Four groups were created based on depression and CKD status: Group 1, no depression and no CKD; Group 2, depression present and no CKD; Group 3: no depression and CKD present; Group 4: depression present and CKD present. Moderate CKD was defined as an estimated glomerular filtration rate of 15–59 mL/min/1.73 m(2) (Stage 3–4) or one-time urine albumin-to-creatinine ratio ≥ 30 mg/g. Depression was defined as the 9-item Patient Health Questionnaire score of 10 or more. Cox proportional hazards regression models were used to calculate the multivariate-adjusted hazard ratios (HRs) of death for Group 4 with other groups. RESULTS: Over a mean follow-up of 5.8 years, 1783 deaths were documented, including 338 deaths from CVD. The HR for all-cause mortality in Group 4 was 3.62 (95% CI: 2.69–4.87), 2.99 (1.92–4.66), and 1.75 (1.29–2.37) when compared with Group 1, 2, and 3, respectively. The HR for CVD mortality in Group 4 was 3.89 (1.68–9.00), 1.90 (0.86–4.21), and 1.97 (1.17–3.32) when compared with Group 1, 2, and 3, respectively. CONCLUSIONS: There might be a synergistic effect of depression and moderate CKD on all-cause mortality. Moreover, depression might increase the risk of CVD mortality in individuals with moderate CKD. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12882-022-02957-7.
format Online
Article
Text
id pubmed-9554995
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-95549952022-10-13 The synergistic effect of depression and moderate chronic kidney disease on the all-cause and cardiovascular disease mortality among adults: a retrospective cohort study Meng, Fanchao Qi, Yanjie Chen, Xu Yan, Xiuping Huang, Huanhuan He, Fan BMC Nephrol Research BACKGROUND: The relationship between the coexistence of depression and moderate chronic kidney disease (CKD) and mortality is unclear. We aimed to investigate whether there is a synergistic effect of depression and moderate CKD on the all-cause and cardiovascular disease (CVD) mortality among adults. METHODS: We studied 24,412 participants from the National Health and Nutrition Examination Survey 2005–2014 with a mortality follow-up assessment in 2015. Four groups were created based on depression and CKD status: Group 1, no depression and no CKD; Group 2, depression present and no CKD; Group 3: no depression and CKD present; Group 4: depression present and CKD present. Moderate CKD was defined as an estimated glomerular filtration rate of 15–59 mL/min/1.73 m(2) (Stage 3–4) or one-time urine albumin-to-creatinine ratio ≥ 30 mg/g. Depression was defined as the 9-item Patient Health Questionnaire score of 10 or more. Cox proportional hazards regression models were used to calculate the multivariate-adjusted hazard ratios (HRs) of death for Group 4 with other groups. RESULTS: Over a mean follow-up of 5.8 years, 1783 deaths were documented, including 338 deaths from CVD. The HR for all-cause mortality in Group 4 was 3.62 (95% CI: 2.69–4.87), 2.99 (1.92–4.66), and 1.75 (1.29–2.37) when compared with Group 1, 2, and 3, respectively. The HR for CVD mortality in Group 4 was 3.89 (1.68–9.00), 1.90 (0.86–4.21), and 1.97 (1.17–3.32) when compared with Group 1, 2, and 3, respectively. CONCLUSIONS: There might be a synergistic effect of depression and moderate CKD on all-cause mortality. Moreover, depression might increase the risk of CVD mortality in individuals with moderate CKD. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12882-022-02957-7. BioMed Central 2022-10-11 /pmc/articles/PMC9554995/ /pubmed/36221061 http://dx.doi.org/10.1186/s12882-022-02957-7 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Meng, Fanchao
Qi, Yanjie
Chen, Xu
Yan, Xiuping
Huang, Huanhuan
He, Fan
The synergistic effect of depression and moderate chronic kidney disease on the all-cause and cardiovascular disease mortality among adults: a retrospective cohort study
title The synergistic effect of depression and moderate chronic kidney disease on the all-cause and cardiovascular disease mortality among adults: a retrospective cohort study
title_full The synergistic effect of depression and moderate chronic kidney disease on the all-cause and cardiovascular disease mortality among adults: a retrospective cohort study
title_fullStr The synergistic effect of depression and moderate chronic kidney disease on the all-cause and cardiovascular disease mortality among adults: a retrospective cohort study
title_full_unstemmed The synergistic effect of depression and moderate chronic kidney disease on the all-cause and cardiovascular disease mortality among adults: a retrospective cohort study
title_short The synergistic effect of depression and moderate chronic kidney disease on the all-cause and cardiovascular disease mortality among adults: a retrospective cohort study
title_sort synergistic effect of depression and moderate chronic kidney disease on the all-cause and cardiovascular disease mortality among adults: a retrospective cohort study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9554995/
https://www.ncbi.nlm.nih.gov/pubmed/36221061
http://dx.doi.org/10.1186/s12882-022-02957-7
work_keys_str_mv AT mengfanchao thesynergisticeffectofdepressionandmoderatechronickidneydiseaseontheallcauseandcardiovasculardiseasemortalityamongadultsaretrospectivecohortstudy
AT qiyanjie thesynergisticeffectofdepressionandmoderatechronickidneydiseaseontheallcauseandcardiovasculardiseasemortalityamongadultsaretrospectivecohortstudy
AT chenxu thesynergisticeffectofdepressionandmoderatechronickidneydiseaseontheallcauseandcardiovasculardiseasemortalityamongadultsaretrospectivecohortstudy
AT yanxiuping thesynergisticeffectofdepressionandmoderatechronickidneydiseaseontheallcauseandcardiovasculardiseasemortalityamongadultsaretrospectivecohortstudy
AT huanghuanhuan thesynergisticeffectofdepressionandmoderatechronickidneydiseaseontheallcauseandcardiovasculardiseasemortalityamongadultsaretrospectivecohortstudy
AT hefan thesynergisticeffectofdepressionandmoderatechronickidneydiseaseontheallcauseandcardiovasculardiseasemortalityamongadultsaretrospectivecohortstudy
AT mengfanchao synergisticeffectofdepressionandmoderatechronickidneydiseaseontheallcauseandcardiovasculardiseasemortalityamongadultsaretrospectivecohortstudy
AT qiyanjie synergisticeffectofdepressionandmoderatechronickidneydiseaseontheallcauseandcardiovasculardiseasemortalityamongadultsaretrospectivecohortstudy
AT chenxu synergisticeffectofdepressionandmoderatechronickidneydiseaseontheallcauseandcardiovasculardiseasemortalityamongadultsaretrospectivecohortstudy
AT yanxiuping synergisticeffectofdepressionandmoderatechronickidneydiseaseontheallcauseandcardiovasculardiseasemortalityamongadultsaretrospectivecohortstudy
AT huanghuanhuan synergisticeffectofdepressionandmoderatechronickidneydiseaseontheallcauseandcardiovasculardiseasemortalityamongadultsaretrospectivecohortstudy
AT hefan synergisticeffectofdepressionandmoderatechronickidneydiseaseontheallcauseandcardiovasculardiseasemortalityamongadultsaretrospectivecohortstudy